Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Apple Turns 50: From Garage Startup to AI Crossroads 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
MINNEAPOLIS, Sept. 12, 2016 -- Vital Images, Inc. (Vital), a Minneapolis-based advanced medical imaging and informatics company, is pleased to announce the support of Nuance PowerScribe® 360 Reporting and PenRad™ PenLung™ Lung Screening Management system in its comprehensive Lung Screening solution. The Vitrea® CT Lung Analysis application helps clinicians standardize the diagnosis of lung nodules, while the solution’s workflow system facilitates management of lung screening treatment plans.
Nuance’s PowerScribe 360 is the market-leading speech recognition technology for radiology, providing accurate, flexible and rapid reporting that is consistent and actionable. The high-quality reports generated by PowerScribe 360 can help healthcare organizations improve both patient care and physician satisfaction, and optimize billing and reimbursement.
PenLung by PenRad is a unified software solution that helps radiology departments and imaging facilities manage patients participating in low-dose computed tomography (LDCT) lung screening programs. It collects smoking and environmental risk history through automated web and tablet calculators to manage patient eligibility and export of the lung registry for reimbursement.
“We are excited to announce the support of PowerScribe 360 and PenLung as part of our comprehensive Lung Screening solution offering to healthcare organizations,” says Jim Litterer, President and CEO of Vital. “The integration of these powerful tools with CT Lung Screening can help providers continue to improve patient outcomes by streamlining both workflow and treatment plan management.”
About Vital Images, Inc.
Vital Images, Inc., a Toshiba Medical Systems Group company, is a leading provider of diagnostic imaging and enterprise informatics solutions to help healthcare organizations deliver exceptional care while optimizing resources across multi-facility organizations. The company's solutions are scalable to meet the unique needs of hospitals and imaging centers and are accessible throughout the enterprise anytime, anywhere. For more information, visit www.vitalimages.com or join the conversation on Twitter, LinkedIn and YouTube.
Vitrea is a trademark of Vital Images, Inc.
Marks not owned by Vital Images, Inc. are the property of their respective holders.
AT VITAL IMAGES: Aaron Wangen (952) 487-9632 [email protected] www.vitalimages.com
